Abstracts - faqs.org

Abstracts

Business, regional

Search abstracts:
Abstracts » Business, regional

A local company sinks its teeth into a new drug

Article Abstract:

Warminster, PA-based OraPharma Inc. has just financed the development of a new antibiotic treatment for periodontal disease. The drug is currently undergoing Phase III clinical trials. The company wants to file a New Drug Application with the FDA before the end of 1999, and then launch it on the market by early 2001. OraPharma calls its product a minocycline periodontal therapeutic system. The drug is made up of an antibiotic imbedded in small polymer balls.

Comment:

Warminster, PA-based OraPharma Inc. has just financed the development of a new antibiotic treatment for periodontal disease.

Publisher: Philadelphia Newspapers, Inc.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 1999
Product development, Medicinal and Botanical Manufacturing, Bulk Antibiotics, OraPharma Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Nasal flu vaccine isn't selling well amid shortage

Article Abstract:

MedImmune Inc. has agreed to produce three million doses of its FluMist spray flu vaccine in 2005 with the encouragement of federal health officials. However, it is estimated that the company would be able to sell only about one million doses due to its inability to persuade Americans to adopt a nasal spray alternative to the standard flu shot.

Author: Rosenwald, Michael S.
Publisher: Philadelphia Newspapers, Inc.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 2005
Marketing procedures, Pharmaceutical preparations, Pharmaceutical industry, Marketing, Company marketing practices, MedImmune Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States
Similar abstracts:
  • Abstracts: Telephone firms ask Penna. to relax rules. Comcast Cable's plan: Witty self-flagellation
  • Abstracts: AstraZeneca counts on robots to speed search. Glaxo flu vaccine is offered to FDA: The drug maker is seeking speedy approval for selling its Fluarix in the U.S. to help with the expected shortage
  • Abstracts: Nonprofits left in limbo as Pa. reviews funding. Dissent brews on beer tax. Camera shops find pictures of success are hard to capture
  • Abstracts: CoreStates Securities to pay $541,000 in brokerage dispute. Amtrak freight operation is upheld. Cyber-thieves delight in one-stop swiping
  • Abstracts: In search of a painkiller free of side effects. Giving bolts a new twist. Digital solution to a medical problem
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.